Dow Up 0.73% Nasdaq Up 1.22%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.38 Down 0.01(0.42%) 9:51AM EDT - Nasdaq Real Time Price
Prev Close:2.39
Open:2.34
Bid:2.36 x 3200
Ask:2.37 x 7100
1y Target Est:5.25
Beta:1.64
Next Earnings Date:N/A
Day's Range:2.34 - 2.39
52wk Range:1.60 - 4.25
Volume:96,503
Avg Vol (3m):1,091,380
Market Cap:345.43M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICDown 0.42%345.43M
BMYDown 0.70%97.15B
RHHBYDown 0.30%251.89B
SNYUp 0.80%120.88B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.59
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback